We care about the people we serve
At SkylineDx, we’re on a mission to transform healthcare by offering scientifically robust and clinically relevant molecular diagnostic tests that address a current unmet medical need.
Whether it regards diagnosing faster, deselecting patients for procedures, or finding therapy responders, our tests support care providers and patients in their treatment decision-making. Each test delves into the biology of the disease and analyses a patient’s unique gene expression, unraveling their individual disease profile and empowering those involved to make informed choices at pivotal moments in their lives.
We LIVE to make a difference
Our innovative medical technology is already making a significant impact. Our team is driven by scientific research, data science, and clinical relevance. It is not a solo journey. While we are disease agnostic, we pride ourselves in having a very clear focus: bridging the gap between (academically) discovered biomarkers and commercially available diagnostic assays. This means we collaborate with esteemed medical (academic) centers in the United States and Europe to further develop their foundational and instrumental work in biomarker discovery. Once launched commercially, we sign commercial partnerships to strengthen the sales and marketing efforts, expanding the test’s footprint globally.
Value-based healthcare starts with comprehensive molecular diagnostics that address a clinical unmet need. In collaboration with our partners, we are dedicated to making these tests available in the real-world setting through a focus on reimbursement and market access for patients.
For us it's personal
SkylineDx is founded by passionate innovators who set out on a journey to positively change healthcare each step of the way, with a relentless drive to make a difference. Over the years, as we faced challenges and celebrated victories, we always remained steadfast in our commitment. Today, our story continues to unfold as we have diagnostics on the market available to support decision-making and even more in our pipeline.
Experienced Team
Our interdisciplinary team ensures thorough, scientifically robust development and effective marketing of assays
Collaboration Model
Partnering with discovery – and commercial partner experts, allow us to focus on what we do best: getting molecular diagnostics from bench to bedside
Clinical Expert Network
Our extensive clinical network ensures patient-centric care as a foundation throughout our assay development process
Decade of Excellence
With over 10 years of experience in molecular diagnostics, we lead innovation for personalized healthcare
What we do
We believe that scientifically robust and clinically meaningful biomarkers should find their way to patients, therefore we don’t focus on one disease or group of diseases specifically. We encourage you to submit your biomarker discovery or your proposal to write a grant application with us. We are always open to new collaborations. Whether it regards collaborations to generate additional evidence on products already in our pipeline or collaborations outside our current R&D Programs.
STRIX Program
Before a new molecular biomarker enters our Research & Development Programs, all discoveries and research opportunities are thoroughly evaluated in our dedicated STRIX (Systematic, Translational R&D Workflow, building on Integrated Expertise) Program. Our interdisciplinary team searches, screens, and evaluates hundreds of high-potential biomarkers a year, selecting the most promising. We then partner with the inventor and potentially license the related intellectual property (IP) that allows us to develop and commercialize the biomarker.
We form strong partnerships with technology transfer offices from hospitals and academia, as well as close collaboration with the involved clinicians and researchers directly. When a biomarker progresses from STRIX to one of our R&D Programs, we might file and develop additional IP.
Strix is a genus of the owl family and symbolizes wisdom and perception. Its sharp perception of details, broad view, and ability to see in the dark closely resembles what the STRIX Program is capable of making visible which would otherwise remain hidden.
Falcon R&D Program for Dermato-Oncology
Melanoma is an aggressive type of skin cancer. In melanoma, we have an extensive collaboration named the Falcon R&D Program. As the falcon bird is known as an intelligent creature with unprecedented senses and skills, our R&D program is uniquely equipped to unveil new, detailed insights in the genomic, biologic and clinical nature of melanoma.Â
Under the wings of the Falcon R&D Program, a series of specific studies and projects has been initiated, aimed at developing and introducing an array of diagnostic utilities, to provide physicians with the tools to optimize the clinical pathway of their patients. Not by coincidence, related series of studies are named after birds of prey in the Falcon family.
Panthera R&D Program for Hemato-Oncology
The Panthera Program focuses on hematological malignancies, cancers that develop in blood cells. Tackling hematological cancer requires strength and intelligence. Conditions such as multiple myeloma hide deep in the bone marrow.
Delphia R&D Program for Infectious and Inflammatory Diseases
Infectious and Inflammatory diseases consist of many disorders and studies suggest that a dysfunction of the immune system seems to be an important shared characteristic. The first disease in this program is Kawasaki disease.
Let's work together
Learn our story
At the core, our greatest asset is our people. From visionary leaders to talented scientists and dedicated staff. Each member of the SkylineDx team is united by a shared commitment to make a difference. Our teams are structured to advance the research and development in 3 dedicated programs, personified by animal genera: Falcon R&D Program for Dermato-Oncology, Panthera R&D Program for hematology and Delphia R&D Program for infectious & inflammatory diseases.
Meet our leadership team
Our dedicated, international team of over 70 experts is led by our global leadership team.
Our trusted collaborations
What others have to say about us
SkylineDx is ISO 13485:2016 certified